Cargando…
Seasonal malaria chemoprevention: successes and missed opportunities
Seasonal malaria chemoprevention (SMC) was recommended in 2012 for young children in the Sahel during the peak malaria transmission season. Children are given a single dose of sulfadoxine/pyrimethamine combined with a 3-day course of amodiaquine, once a month for up to 4 months. Roll-out and scale-u...
Autores principales: | Coldiron, Matthew E., Von Seidlein, Lorenz, Grais, Rebecca F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704360/ https://www.ncbi.nlm.nih.gov/pubmed/29183327 http://dx.doi.org/10.1186/s12936-017-2132-1 |
Ejemplares similares
-
Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger
por: Coldiron, Matthew E., et al.
Publicado: (2021) -
Adherence and Population Pharmacokinetic Properties of Amodiaquine When Used for Seasonal Malaria Chemoprevention in African Children
por: Ding, Junjie, et al.
Publicado: (2019) -
Clinical diagnostic evaluation of HRP2 and pLDH-based rapid diagnostic tests for malaria in an area receiving seasonal malaria chemoprevention in Niger
por: Coldiron, Matthew E., et al.
Publicado: (2019) -
Challenges to replace ACT as first-line drug
por: Phyo, Aung Pyae, et al.
Publicado: (2017) -
Telemedicine During the COVID-19 in Italy: A Missed Opportunity?
por: Omboni, Stefano
Publicado: (2020)